Therapy with bortezomib plus dexamethasone induces osteoblast activation in responsive patients with multiple myeloma.
第一作者:
Shuji,Ozaki
第一单位:
Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Kuramoto, Tokushima, Japan. ozakishu@clin.med.tokushima-u.ac.jp
作者:
医学主题词
老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);骨和骨组织(Bone and Bones);硼酸化物(Boronic Acids);地塞米松(Dexamethasone);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);成骨细胞(Osteoblasts);骨生成(Osteogenesis);蛋白酶抑制药(Protease Inhibitors);吡嗪类(Pyrazines);治疗结果(Treatment Outcome)
DOI
10.1532/IJH97.07030
PMID
17875535
发布时间
2022-03-10
- 浏览8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



